Skip to content
FFF145145145

Drawing based on the description in the official product monograph. No photo yet.

“145 mg tablets: each white to off-white biconvex, oblong tablet contains 145 mg of fenofibrate and is embossed with the "F" on one side and "145" on the other”

F 145 pill

Pill with imprint F 145 is white, capsule and has been identified as Fenofibrate 145.0 mg. It is used for high cholesterol, high triglycerides and heart disease. It is supplied by Sandoz Canada Incorporated.

Sold in Canada

Fenofibrate 145.0 mg

Brand
Sandoz Fenofibrate E
Imprint
F 145
Strength
145.0 mg
Used for
High cholesterol, high triglycerides and heart disease
Color
White
Shape
Capsule / oblong
Form
Tablet
Manufacturer
Sandoz Canada Incorporated
Drug class
Peroxisome proliferator-activated receptor alpha agonist
Sold in
Canada
DIN
02390701

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Fenofibrate pills and guides

What is Fenofibrate used for?

Fenofibrate is used for high cholesterol, high triglycerides and heart disease.

Medicine type
Peroxisome proliferator-activated receptor alpha agonist
Official uses from the US prescribing label

Primary Hypercholesterolemia or Mixed Dyslipidemia

Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

Severe Hypertriglyceridemia

Fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. Improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention.

Markedly elevated levels of serum triglycerides (e.g. > 2,000 mg/dL) may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been adequately studied.

Important Limitations of Use

Fenofibrate at a dose equivalent to 160 mg of fenofibrate tablet was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes mellitus.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows F 145. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, capsule.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Sandoz Fenofibrate E by Sandoz Canada Incorporated.

In Canada: prescription only.

Ingredients

Active: Fenofibrate

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Fenofibrate pills